Literature DB >> 7530737

Hepatocellular carcinoma in primary biliary cirrhosis.

F Farinati1, A Floreani, N De Maria, S Fagiuoli, R Naccarato, M Chiaramonte.   

Abstract

Primary biliary cirrhosis is considered a low risk for the development of hepatocellular carcinoma. We evaluated the incidence of hepatocellular carcinoma in a cohort of 89 female primary biliary cirrhosis patients and, as a control group in 73 female patients with cirrhosis of a different etiology. The patients underwent ultrasound and alfa-fetoprotein determination every 6 months. Two patients developed hepatocellular carcinoma in the primary biliary cirrhosis and three in the control group, respectively. The Relative Risk for hepatocellular carcinoma in primary biliary cirrhosis patients was 0.7. However, when considering only stage IV, primary biliary cirrhosis patients with cirrhosis, the Relative Risk was actually 1.5 with respect to controls, with 1.4% cases of hepatocellular carcinoma per year. These data suggest that the risk of hepatocellular carcinoma is similar in female patients with primary biliary cirrhosis and in female patients with cirrhosis of a different etiology.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7530737     DOI: 10.1016/s0168-8278(05)80307-1

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  7 in total

1.  Right hepatic lobectomy for hepatocellular carcinoma which developed in primary biliary cirrhosis: report of a case.

Authors:  T Morimoto; G Honda; Y Kawai; T Hirose; T Nishio; N Shinkura; Y Iimuro; N Yamamoto; Y Yamamoto; I Ikai; Y Shimahara; Y Yamaoka
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

2.  Screening for hepatocellular carcinoma.

Authors:  Singal Amit; Marrero Jorge A
Journal:  Gastroenterol Hepatol (N Y)       Date:  2008-03

Review 3.  Incidence and risk factors for hepatocellular carcinoma in primary biliary cirrhosis.

Authors:  Guanghua Rong; Hong Wang; Christopher L Bowlus; Chunping Wang; Yinying Lu; Zhen Zeng; Jianhui Qu; Min Lou; Yan Chen; Linjing An; Yongping Yang; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-06       Impact factor: 8.667

4.  Incidence of Hepatocellular Carcinoma in Primary Biliary Cholangitis: A Systematic Review and Meta-Analysis.

Authors:  Yamini Natarajan; Aylin Tansel; Parth Patel; Kingsley Emologu; Richa Shukla; Zeeshan Qureshi; Hashem B El-Serag; Aaron P Thrift; Fasiha Kanwal
Journal:  Dig Dis Sci       Date:  2020-08-02       Impact factor: 3.199

Review 5.  Surveillance for hepatocellular carcinoma in chronic liver disease: evidence and controversies.

Authors:  Suzanne van Meer; Robert A de Man; Peter D Siersema; Karel J van Erpecum
Journal:  World J Gastroenterol       Date:  2013-10-28       Impact factor: 5.742

6.  Hepatocellular carcinoma in patients with autoimmune hepatitis.

Authors:  Andreas Teufel; Arndt Weinmann; Catherine Centner; Anja Piendl; Ansgar W Lohse; Peter R Galle; Stephan Kanzler
Journal:  World J Gastroenterol       Date:  2009-02-07       Impact factor: 5.742

7.  Juvenile Hepatocellular Carcinoma in a Healthy Liver.

Authors:  Sachiyo Onishi; Masahiro Tajika; Tsutomu Tanaka; Keisaku Yamada; Tomoyasu Kamiya; Seiji Natsume; Yasuhiro Shimizu; Yasumasa Niwa
Journal:  Intern Med       Date:  2021-10-19       Impact factor: 1.282

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.